ArticleACS applied materials & interfaces2025
Enhanced Cancer Radiosensitization via Energy Transfer from Eu-Doped GdF
Mileni M Isikawa, Zeinaf Muradova, Toby Morris, João V V Lessa, Fernanda H Borges, Rogéria R Gonçalves, Ross I Berbeco, Eder J Guidelli
Abstract read
In one paragraphArticle in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Mileni M IsikawaDepartamento de Física - FFCLRP, Universidade de São Paulo, Ribeirão Preto, SP 14040-901, Brazil.
Zeinaf MuradovaDepartment of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, United States.
Toby MorrisDepartment of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, United States.
João V V LessaDepartamento de Física - FFCLRP, Universidade de São Paulo, Ribeirão Preto, SP 14040-901, Brazil.
Fernanda H BorgesDepartamento de Química, Center for Nanotechnology and Tissue Engineering & Mater Lumen Laboratory - FFCLRP, Universidade de São Paulo, Ribeirão Preto, SP 14040-901, Brazil.
Rogéria R GonçalvesDepartamento de Química, Center for Nanotechnology and Tissue Engineering & Mater Lumen Laboratory - FFCLRP, Universidade de São Paulo, Ribeirão Preto, SP 14040-901, Brazil.
Ross I BerbecoDepartment of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, United States.ORCID 0000-0002-9076-4535 Eder J GuidelliDepartamento de Física - FFCLRP, Universidade de São Paulo, Ribeirão Preto, SP 14040-901, Brazil.ORCID 0000-0002-4657-5112 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
We synthesized europium-doped gadolinium fluoride (GdF
Indexed as
EuropiumFluoridesGadoliniumMethylene BlueNanoparticlesPhotochemotherapyRadiation-Sensitizing AgentsA549 CellsAnimalsCell SurvivalEnergy TransferHumansMiceSinglet OxygenX-RaysEuropiumFluoridesGadoliniumMethylene BlueRadiation-Sensitizing AgentsSinglet Oxygenenergy transferlanthanidesmicrofluidicphotodynamic therapyradioluminescenceradiotherapy
Identifiers
PMID40907055
PMCPMC12447382
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390